These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5673166)

  • 1. Urokinase.
    Sherry S
    Ann Intern Med; 1968 Sep; 69(3):415-25. PubMed ID: 5673166
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolytic therapy.
    Gallus AS
    Compr Ther; 1976 Apr; 2(4):67-73. PubMed ID: 131019
    [No Abstract]   [Full Text] [Related]  

  • 3. Urokinase therapy in pulmonary thromboembolism.
    Genton E; Wolf PS
    Am Heart J; 1968 Nov; 76(5):628-37. PubMed ID: 5698419
    [No Abstract]   [Full Text] [Related]  

  • 4. Evolution of plasma specific fibrin degradation products during thrombolytic therapy in patients with thrombo-embolism.
    Faivre R; Mirshahi M; Ducellier D; Soria C; Soria J; Mirshahi M; Kieffer Y; Bassand JP; Caen J; Maurat JP
    Thromb Res; 1988 May; 50(4):583-9. PubMed ID: 3413720
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinolytic guidelines in diabetes.
    Sharma GV; Mukerjee DK; Sasahara AA
    Geriatrics; 1982 Apr; 37(4):38-42, 46. PubMed ID: 7060947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary embolism: what happens to the emboligenic focus?].
    Serradimigni A; Philip F; Elias A; Lecorff G
    Haemostasis; 1986; 16 Suppl 4():69-78. PubMed ID: 3770559
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombolytic drugs: quo vadis?
    Verstraete M
    Acta Clin Belg; 1977; 32(6):434-9. PubMed ID: 616754
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinolytic agents.
    Sherry S
    Dis Mon; 1969 May; ():3-32. PubMed ID: 4241828
    [No Abstract]   [Full Text] [Related]  

  • 9. Current developments in thrombolytic therapy.
    Sherry S
    Thromb Diath Haemorrh Suppl; 1973; 56():201-10. PubMed ID: 4617330
    [No Abstract]   [Full Text] [Related]  

  • 10. Current status of thrombolytic therapy.
    Cudkowicz L; Sherry S
    Heart Lung; 1978; 7(1):97-100. PubMed ID: 244489
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombolytic therapy.
    Kakkar VV; Scully MF
    Br Med Bull; 1978 May; 34(2):191-9. PubMed ID: 148935
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic fibrinolysis].
    Straub PW
    Schweiz Med Wochenschr; 1973 May; 103(20):753-7. PubMed ID: 4702993
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrinolytic agents.
    Schmitz-Huebner U; van de Loo J
    Clin Haematol; 1981 Jun; 10(2):481-96. PubMed ID: 7032785
    [No Abstract]   [Full Text] [Related]  

  • 14. Urokinase in pulmonary thromboembolic disease: a preliminary report.
    Dickie K; de Groot W
    Tex Rep Biol Med; 1967; 25(4):613-24. PubMed ID: 6082233
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinolysis and its current usage.
    Rubin RN
    Clin Ther; 1983; 5(3):211-22. PubMed ID: 6342782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current thoughts on venous thromboembolism.
    Browse NL
    Surg Clin North Am; 1974 Feb; 54(1):229-38. PubMed ID: 4814520
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fibrinolytic therapy. Indications and execution].
    Trübestein G
    Dtsch Med Wochenschr; 1985 Sep; 110(37):1417-9. PubMed ID: 4028995
    [No Abstract]   [Full Text] [Related]  

  • 18. [The thrombolytic medications].
    Rignault D
    Presse Med (1893); 1969 Jan; 77(2):55-8. PubMed ID: 4239477
    [No Abstract]   [Full Text] [Related]  

  • 19. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases].
    Verstraete M
    Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombolytic therapy].
    Schimpf K
    Dtsch Med Wochenschr; 1969 Oct; 94(44):2292-4. PubMed ID: 5350098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.